Clinical trial · Interventional

Interest of Procore Needle® for Diagnosis of Lung Cancer

NCT02931461CI-TRIAL-00045375completedN/AClinicalTrials.gov clinicaltrialsPublishedExplore in graph →

Summary

Brief summary (as posted)

The ProCore ultrasound biopsy needle, used primarily to obtain intra-abdominal tissue core biopsies, has not been widely used for endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA). In this study the investigators are going to evaluate the utility of the ProCore needle for sampling mediastinal or hilar lymph nodes during EBUS-TBNA versus standard 22 gauge needle for diagnosis of lung cancer.

Conditions

Conditions (1)

Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.

Condition (as posted)	Mapped entity	Match	Confidence
Endobronchial Transbronchial Needle Aspiration Lung Cancer Procore	—	UNRESOLVED	—

Interventions

Interventions (1)

Intervention	Type	Mapped drug	Match
Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration	Procedure	—	UNRESOLVED

Design

Arms and outcomes

Arms (2)

type
EXPERIMENTAL
label
needle Procore ®
interventionNames
1. Procedure: Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration
type
ACTIVE_COMPARATOR
label
needle Cook®
interventionNames
1. Procedure: Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration

Primary outcomes (1)

measure
Proportion of histological diagnoses for each needle
timeFrame
6 months

Eligibility

Eligibility (as posted)

Sex: All
Minimum age: 18 Years

Show eligibility criteria text

Inclusion Criteria:

* mediastinal lymphadenopathy \>10 millimeters
* lung cancer suspected

Exclusion Criteria:

* coagulopathy contraindication for midazolam contraindication for bronchoscopy

References

Publications (0)

Data not yet available

No reference posted for this study.